zoledronic acid has been researched along with Granuloma, Plasma Cell, Orbital in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ajlan, RS; Champion, M; Herrera, I; Kam, Y; Whittaker, TJ | 1 |
Arroyo, JG; Freitag, SK; Lefebvre, DR; Mandeville, JT; Torun, N; Yonekawa, Y | 1 |
Albiani, DA; Anderson, DP; Barton, JJ; Seth, A | 1 |
Bedrossian, EH; Peterson, JD | 1 |
Newman, SA; Phillips, PM | 1 |
2 review(s) available for zoledronic acid and Granuloma, Plasma Cell, Orbital
Article | Year |
---|---|
A Case Series and Review of Bisphosphonate-associated Orbital Inflammation.
Topics: Aged; Alendronate; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Imidazoles; Magnetic Resonance Imaging; Male; Middle Aged; Orbital Cellulitis; Orbital Pseudotumor; Remission, Spontaneous; Retrospective Studies; Zoledronic Acid | 2016 |
Bisphosphonate-associated orbital inflammation--a case report and review.
Topics: Bone Density Conservation Agents; Diphosphonates; Edema; Eye Pain; Eyelid Diseases; Female; Humans; Imidazoles; Infusions, Intravenous; Middle Aged; Orbital Pseudotumor; Osteoporosis, Postmenopausal; Tomography, X-Ray Computed; Uveitis, Anterior; Vision Disorders; Zoledronic Acid | 2012 |
3 other study(ies) available for zoledronic acid and Granuloma, Plasma Cell, Orbital
Article | Year |
---|---|
Bisphosphonate-induced orbital inflammation in a patient on chronic immunosuppressive therapy.
Topics: Administration, Oral; Bone Density Conservation Agents; Cyclosporine; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Infusions, Intravenous; Lupus Erythematosus, Systemic; Magnetic Resonance Imaging; Middle Aged; Orbital Pseudotumor; Osteoporosis, Postmenopausal; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Prednisone; Sjogren's Syndrome; Zoledronic Acid | 2019 |
Orbital inflammation and optic neuropathy with zoledronic acid for metastatic prostate cancer.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Bone Density Conservation Agents; Diphosphonates; Drug Therapy, Combination; Fluorescein Angiography; Glucocorticoids; Humans; Ibuprofen; Imidazoles; Magnetic Resonance Imaging; Male; Optic Neuropathy, Ischemic; Orbital Pseudotumor; Prednisone; Prostatic Neoplasms; Zoledronic Acid | 2009 |
Orbital inflammatory disease after intravenous infusion of zoledronate for treatment of metastatic renal cell carcinoma.
Topics: Administration, Oral; Bone Density Conservation Agents; Bone Neoplasms; Carcinoma, Renal Cell; Diphosphonates; Glucocorticoids; Humans; Imidazoles; Infusions, Intravenous; Kidney Neoplasms; Male; Middle Aged; Orbital Pseudotumor; Prednisone; Tomography, X-Ray Computed; Zoledronic Acid | 2008 |